UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

PLoS medicine, 2007-03, Vol.4 (3), p.e90

2007

Volltextzugriff (PDF)

Papillomes intra-ductaux

Reproduction humaine et hormones, 2012-06, Vol.25 (1)

2012

Volltextzugriff (PDF)

Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype

Radiology, 2015-11, Vol.277 (2), p.358-371

2015

Volltextzugriff (PDF)

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer

Oncotarget, 2017-05, Vol.8 (21), p.35205-35221

2017

Volltextzugriff (PDF)

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Oncogene, 2002-10, Vol.21 (49), p.7593-7597

2002

Volltextzugriff (PDF)

Estrogen receptor‐positive/human epidermal growth factor receptor 2‐negative breast tumors

Cancer, 2013-06, Vol.119 (11), p.1960-1968

2013

Volltextzugriff (PDF)

A misleading breast metastasis of medullary thyroid carcinoma

Annales de pathologie, 2019-02, Vol.39 (1), p.9-13

2019

Volltextzugriff (PDF)

Métastase mammaire d’un carcinome médullaire thyroïdien : un challenge diagnostique

Annales de pathologie, 2019-02, Vol.39 (1), p.9-13

2019

Volltextzugriff (PDF)

Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer

The Journal of nuclear medicine (1978), 2015-06, Vol.56 (6), p.824-831

2015

Volltextzugriff (PDF)

Breast Intracystic Papillary Carcinoma: An Update

The breast journal, 2009-11, Vol.15 (6), p.639-644

2009

Volltextzugriff (PDF)

Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer

The Journal of nuclear medicine (1978), 2013-03, Vol.54 (3), p.341-349

2013

Volltextzugriff (PDF)

Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers

Oncogene, 1999-12, Vol.18 (54), p.7834-7837

1999

Volltextzugriff (PDF)

Breast metastasis of ileal endocrine carcinoma

Annales de pathologie, 2011-04, Vol.31 (2), p.112-114

2011

Volltextzugriff (PDF)

Primary Hyperparathyroidism from Parathyroid Microadenoma: Specific Features and Implications for a Surgical Strategy in the Era of Minimally Invasive Parathyroidectomy

Journal of the American College of Surgeons, 2010-04, Vol.210 (4), p.456-462

2010

Volltextzugriff (PDF)

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer

JNCI : Journal of the National Cancer Institute, 2012-12, Vol.104 (24), p.1879-1887

2012

Volltextzugriff (PDF)

Une découverte intramammaire inattendue

Annales de pathologie, 2011-04, Vol.31 (2), p.112-114

2011

Volltextzugriff (PDF)

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

European journal of nuclear medicine and molecular imaging, 2011-03, Vol.38 (3), p.426-435

2011

Volltextzugriff (PDF)

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

European journal of nuclear medicine and molecular imaging, 2015-10, Vol.42 (11), p.1682-1691

2015

Volltextzugriff (PDF)

F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

The Journal of nuclear medicine (1978), 2016-04, Vol.57 (4), p.536-543

2016

Volltextzugriff (PDF)

p53 in breast cancer subtypes and new insights into response to chemotherapy

Breast (Edinburgh), 2013-08, Vol.22, p.S27-S29

2013

Volltextzugriff (PDF)

Prospective Clinical Utility Study of the Use of the 21‐Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor‐Positive Early Invasive Breast Cancer: Results From the SWITCH Study

The oncologist (Dayton, Ohio), 2015-08, Vol.20 (8), p.873-879

2015

Volltextzugriff (PDF)

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15

Breast cancer research : BCR, 2013-05, Vol.15 (3), p.R37-R37, Article R37

2013

Volltextzugriff (PDF)

Expérience de l’Hôpital Saint-Louis dans le cancer du sein chez l’homme : revue des caractéristiques de 44 cas et recherche de l’expression du récepteur aux androgènes

Reproduction humaine et hormones, 2012-06, Vol.25 (1)

2012

Volltextzugriff (PDF)

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy

Cancer, 2013-06, Vol.119 (11), p.1960-1968

2013

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(74)

Sprache

Englisch
(66)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Female
(32)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Middle Aged
(25)
Oncology
(21)
Breast Cancer
(20)
Tumors
(18)
Adult
(17)
Aged
(16)
Breast Neoplasms - Pathology
(16)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Breast Neoplasms - Drug Therapy
(12)
Chemotherapy
(10)
Pathology
(10)
Prognosis
(10)
Life Sciences
(9)
Treatment Outcome
(9)
Breast Neoplasms - Diagnostic Imaging
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

Papillomes intra-ductaux

Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Estrogen receptor‐positive/human epidermal growth factor receptor 2‐negative breast tumors

A misleading breast metastasis of medullary thyroid carcinoma

Métastase mammaire d’un carcinome médullaire thyroïdien : un challenge diagnostique

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC

Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer

Breast Intracystic Papillary Carcinoma: An Update

Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer

Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers

Breast metastasis of ileal endocrine carcinoma

Primary Hyperparathyroidism from Parathyroid Microadenoma: Specific Features and Implications for a Surgical Strategy in the Era of Minimally Invasive Parathyroidectomy

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer

Une découverte intramammaire inattendue

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

p53 in breast cancer subtypes and new insights into response to chemotherapy

Prospective Clinical Utility Study of the Use of the 21‐Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor‐Positive Early Invasive Breast Cancer: Results From the SWITCH Study

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15

Expérience de l’Hôpital Saint-Louis dans le cancer du sein chez l’homme : revue des caractéristiques de 44 cas et recherche de l’expression du récepteur aux androgènes

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy

Suchergebnisse filtern